WallStreetZenWallStreetZen

NYSEMKT: SER
Serina Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Serina Therapeutics earnings were -$19.4M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest SER earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$3.6M, down 21.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SER reported annual earnings of -$19.4M, with 74.5% growth.

SER earnings history

Current Revenue
$130.0k
Current Earnings
-$19.4M
Current Profit Margin
-14,950.8%

SER Return on Equity

Current Company
-1,487.6%
Current Industry
-31.4%
Current Market
28.9%
SER's Return on Equity (-1,487.6%)... subscribe to Premium to read more.
High Return on Equity Performance

SER Return on Assets

Current Company
-221.9%
Current Industry
-9.6%
SER is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SER announces earnings.

SER Return on Capital Employed

Current Company
-559.36%
Current Industry
-3.7%
SER has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SER vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SER-$18.68M-$19.44MN/A-$1.91
GRML-$7.50M-$11.29MN/A-$0.32
LGVN-$21.48M-$22.70MN/A-$1.29
TPST-$24.69M-$26.26MN/A-$6.33
JSPR-$73.58M-$75.80MN/A-$3.95
View Top Biotech Stocks

Serina Therapeutics Earnings Reports & History FAQ

What were Serina Therapeutics's earnings last quarter?

Serina Therapeutics (NYSEMKT: SER) reported Q4 2025 earnings per share (EPS) of -$0.31, up 14.81% year over year. Total SER earnings for the quarter were -$3.59 million. In the same quarter last year, Serina Therapeutics's earnings per share (EPS) was -$0.27.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.

Is Serina Therapeutics profitable or losing money?

As of the last Serina Therapeutics earnings report, Serina Therapeutics is currently losing money. Serina Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$19.18 million, a 72.17% increase year over year.

What was SER's earnings growth in the past year?

As of Serina Therapeutics's earnings date in Q2 2026, Serina Therapeutics's earnings has grown year over year. SER earnings in the past year totalled -$19.44 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.